Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 2/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | STS | P08842 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6406510 | 0.87 | MAPT (0.50) | MAPTALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL5563981 | 0.86 | ALDH1A1 (0.50) | MAPTALDH1A1SMN1; SMN2NPC1CA12 | |
| SCHEMBL4027167 | 0.81 | MAPT (0.61) | MAPTALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL7917653 | 0.81 | ALDH1A1 (0.50) | MAPTALDH1A1CA12CA9HPGD | |
| SCHEMBL11050677 | 0.80 | ALDH1A1 (0.44) | MAPTALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL35155 | 0.79 | ALDH1A1 (0.48) | ALDH1A1CA12CA9LMNACA1 | |
| SCHEMBL601340 | 0.79 | ALDH1A1 (0.58) | MAPTALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL28229 | 0.79 | PTGS2 (0.57) | MAPTALDH1A1RAB9ASMN1; SMN2NPC1 | |
| SCHEMBL40244 | 0.79 | CA2 (0.61) | ALDH1A1RAB9ASMN1; SMN2CA12CA9 | |
| SCHEMBL7646230 | 0.79 | ALDH1A1 (0.58) | MAPTALDH1A1RAB9ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 699 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692062-A1 | NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME | Amorepacific Corporation (KR) | 2026-02-11 | — | — | EP | claimed |
| CN-118833938-A | Solid slow-release scale inhibitor and preparation method thereof | 宝武精高(安徽)科技有限公司 | 2024-10-25 | — | — | CN | claimed |
| WO-2024205303-A1 | NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME | (주)아모레퍼시픽 | 2024-10-03 | — | — | WO | claimed |
| CN-118352513-B | Glass-state MOFs coated positive electrode material, preparation method thereof and secondary battery | 江苏蓝固新能源科技有限公司 | 2024-09-17 | — | — | CN | claimed |
| CN-118359521-A | Preparation method of thioether or thioester compound | 中国药科大学 | 2024-07-19 | — | — | CN | claimed |
| CN-118352513-A | Glass-state MOFs coated positive electrode material, preparation method thereof and secondary battery | 江苏蓝固新能源科技有限公司 | 2024-07-16 | — | — | CN | claimed |
| WO-2016111658-A1 | SYNTHESIS OF THIOSEMICARBAZONE DERIVATIVES COMPRISING SULPHONAMIDE GROUP WITH POTENTIAL ANTICONVULSANT ACTIVITY | IYIDOGAN AYSEGUL (TR) | 2016-07-14 | — | — | WO | claimed |
| CN-104678028-A | Pretreatment and detection method for biogen amine neurotransmitter and detection kit | INST PHARM & TOXICOLOGY AMMS | 2015-06-03 | — | — | CN | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| US-20260144730-A1 | COMPOSITION FOR SKIN ANTI-AGING, SKIN BRIGHTENING OR SKIN REVERSE-AGING CONTAINING AMIDE-BASED COMPOUND | AMOREPACIFIC CORPORATION (KR) | 2026-05-28 | — | — | US | disclosed |
| US-12611404-B2 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | CHEMOCENTRYX, INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-20260083715-A1 | COMPOSITION FOR ENHANCING IMMUNITY CONTAINING AMIDE-BASED COMPOUND | AMOREPACIFIC CORPORATION (KR) | 2026-03-26 | — | — | US | disclosed |
| US-12559455-B2 | Compound as a UBR box domain ligand | AUTOTAC INC. (KR) | 2026-02-24 | — | — | US | disclosed |
| EP-4692062-A1 | NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME | Amorepacific Corporation (KR) | 2026-02-11 | — | — | EP | disclosed |
| EP-0107622-A1 | Benzodioxole derivatives, process for their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1984-05-02 | — | — | EP | disclosed |
| US-4443477-A | ANTICOAGULANTS, ANTILIPEMIC AGENTS | BOEHRINGER MANNHEIM GMBH (DE) | 1984-04-17 | — | — | US | disclosed |
| EP-0087953-A2 | Antibacterial 1-normon-2-yl-heterocyclic compounds | BEECHAM GROUP PLC (GB) | 1983-09-07 | — | — | EP | disclosed |
| EP-0030030-A1 | Derivatives of 2-aminoethanol, processes for their preparation, pharmaceutical compositions containing such compounds and the use the latter | CIBA-GEIGY AG (CH) | 1981-06-10 | — | — | EP | disclosed |
| US-4137408-A | BACTERICIDES, ANTIBIOTICS | WARNER-LAMBERT (US) | 1979-01-30 | — | — | US | disclosed |
| US-4101661-A | PENICILLINS, CEPHALOSPORINS | WARNER-LAMBERT (US) | 1978-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144730-A1 | COMPOSITION FOR SKIN ANTI-AGING, SKIN BRIGHTENING OR SKIN REVERSE-AGING CONTAINING AMIDE-BASED COMPOUND | TYR, ATG13, ARGLU1 | MAPT 3260/4885ALDH1A1 1443/4885RAB9A 123/4885 |
| US-20260083715-A1 | COMPOSITION FOR ENHANCING IMMUNITY CONTAINING AMIDE-BASED COMPOUND | ARG1, MSR1, TLR1 | MAPT 4343/4885ALDH1A1 3501/4885RAB9A 231/4885 |
| US-12611404-B2 | Aza-aryl 1H-pyrazol-1-yl benzene sulfonamides | CCR1, CCR9, CCR8 | MAPT 4870/4885ALDH1A1 2034/4885RAB9A 2176/4885 |
| US-12559455-B2 | Compound as a UBR box domain ligand | UBR4, UBTF, UBQLN1 | MAPT 1338/4885ALDH1A1 1486/4885RAB9A 2068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.